BIT 3.23% 3.0¢ biotron limited

$10 Billion Deal, page-12632

  1. 13,817 Posts.
    lightbulb Created with Sketch. 2342
    Yes - the cost will either have to come from a third party or BIT will struggle to move to a phase 3 trial. Any CR will only go to propping up the company for the next 12 months.

    SP is too low to have a serious attempt at self-funding a phase 3 trial.

    Even with a third party funding the next step, we won't see any huge jump in the SP for a while. - and there will still need to be a CR.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.